Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech ChiefDr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with...
